Combination therapy may be more effective than monotherapy for slowing disease progression in patients with PAH, suggests Meta-analysis

By Dr Deepu

Combination therapy was significantly more effective than monotherapy for slowing disease progression in patients with pulmonary arterial hypertension.
          Investigators found that “compared with treatment with a single drug, combination therapy was associated with a significantly lower risk for clinical disease worsening and disease-related hospital admissions, and it was associated with a trend toward reduced all-cause mortality and pulmonary arterial hypertension (PAH)-related mortality.” The findings were published in Lancet Respiratory Medicine.

Source: read Full article on LANCET